Giovanni Citterio

Increased interleukin-10 serum levels in patients with solid tumours

Claudio Fortis, Marco Foppoli, Luca Gianotti et al. · Cancer Letters · 1996 · 155 citations

Cancer Immunosurveillance, Medicine, Immunology +5

High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial

Andrés J.M. Ferreri, Giovanni Donadoni, Maria Giuseppina Cabras et al. · Journal of Clinical Oncology · 2015 · 115 citations · Full text

Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma

Vanesa Gregorc, Paolo Andrea Zucali, Armando Santoro et al. · Journal of Clinical Oncology · 2010 · 109 citations · Full text

Risk‐tailored <scp>CNS</scp> prophylaxis in a mono‐institutional series of 200 patients with diffuse large B‐cell lymphoma treated in the rituximab era

Andrés J.M. Ferreri, Marta Bruno‐Ventre, Giovanni Donadoni et al. · British Journal of Haematology · 2014 · 103 citations · Full text

Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours

Vanesa Gregorc, Armando Santoro, E. Bennicelli et al. · British Journal of Cancer · 2009 · 84 citations · Full text